National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Hypercalcemia (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 08/20/2008
Symptom Prevalence Among Patients Treated for Hypercalcemia of Malignancy Stratified by Corrected Serum Total Calcium Concentrations at Presentation*

Symptoms  Prevalence (%) by Serum Calcium Concentration 
*Adapted from Ralston et al.[3]
<3.5 mmol/L ≥3.5 mmol/L
Central nervous system symptoms 41 80
Constipation 21 25
Malaise-fatigue 65 50
Anorexia 47 59
Nausea and/or vomiting 22 30
Polyuria and/or polydipsia 34 35
Pain 51 35

References

  1. Ralston SH, Gallacher SJ, Patel U, et al.: Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med 112 (7): 499-504, 1990.  [PUBMED Abstract]


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov